<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>Nada Saleh</submitter><study_type>transcription profiling by array</study_type><organism>Homo sapiens</organism><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16146</full_dataset_link><description>This dataset includes RT-qPCR fold-change expression data for apoptosis-, proliferation-, and inflammation-related genes (BAX, BCL-2, CASPASE-3, P53, Ki-67, and IL-6) in two oral cancer cell lines (HEP-2 and HN-9) treated with free Captopril and Captopril-Montmorillonite nanoparticles (CP-MMT). The study demonstrates the enhanced pro-apoptotic and oxidative stress effects of Captopril nanoparticles compared to free Captopril.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Growth Protocol - Cells were maintained in DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37 °C and 5% CO₂ in a humidified incubator.</sample_protocol><sample_protocol>Scaning - Ct values were exported from the StepOnePlus software and analyzed in Microsoft Excel. Fold changes were computed relative to untreated controls to generate normalized expression data for each target gene.</sample_protocol><sample_protocol>Hybridization - Real-time PCR amplification was carried out using SYBR Green Master Mix on a StepOnePlus™ Real-Time PCR System (Applied Biosystems). Relative mRNA expression levels were calculated using the 2^-ΔΔCt method, with β-actin as the internal control.</sample_protocol><sample_protocol>Sample Collection - Oral squamous carcinoma cell lines (HEP-2 and HN-9) were cultured under standard conditions (37 °C, 5% CO₂) in DMEM supplemented with 10% FBS and antibiotics. Cells were seeded in 6-well plates and treated according to the experimental design.</sample_protocol><sample_protocol>Labeling - cDNA synthesis was performed using a high-capacity cDNA reverse transcription kit (Applied Biosystems) following the manufacturer’s protocol.</sample_protocol><sample_protocol>Sample Treatment - Cells were treated with free Captopril or Captopril-Montmorillonite (CP-MMT) nanoparticles for 48 hours. Untreated cells served as controls.</sample_protocol><sample_protocol>Nucleic Acid Extraction - Total RNA was extracted from treated and control cells using TRIzol reagent according to the manufacturer’s instructions. RNA purity and concentration were determined using a NanoDrop spectrophotometer (260/280 nm ratio).</sample_protocol><figure_sub>MIAME Score</figure_sub><figure_sub>Raw Data</figure_sub><figure_sub>Organization</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><figure_sub>Array Designs</figure_sub><pubmed_authors>Nada Saleh</pubmed_authors><data_protocol>Data Transformation - Relative gene expression values were calculated using the comparative Ct (2^-ΔΔCt) method. Data were normalized to β-actin and presented as fold change relative to control.</data_protocol></additional><is_claimable>false</is_claimable><name>Gene Expression Profiling of Oral Cancer Cell Lines Treated with Captopril and Captopril-Montmorillonite Nanoparticles (CP-MMT)</name><description>This dataset includes RT-qPCR fold-change expression data for apoptosis-, proliferation-, and inflammation-related genes (BAX, BCL-2, CASPASE-3, P53, Ki-67, and IL-6) in two oral cancer cell lines (HEP-2 and HN-9) treated with free Captopril and Captopril-Montmorillonite nanoparticles (CP-MMT). The study demonstrates the enhanced pro-apoptotic and oxidative stress effects of Captopril nanoparticles compared to free Captopril.</description><dates><release>2025-12-08T00:00:00Z</release><modification>2025-12-08T02:01:32.968Z</modification><creation>2025-11-16T13:07:32.017Z</creation></dates><accession>E-MTAB-16146</accession><cross_references><EFO>EFO_0002768</EFO><EFO>EFO_0002944</EFO><EFO>EFO_0003814</EFO><EFO>EFO_0003813</EFO><EFO>EFO_0003789</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0003815</EFO><EFO>EFO_0003969</EFO></cross_references></HashMap>